Your Complete Guide to Global Clinical Research and GCP Compliance
Metrics and KPIs to Monitor the Quality and Timeliness of Investigator’s Brochure (IB) Authoring & Updates Metrics and KPIs to Monitor the Quality and Timeliness of Investigator’s Brochure (IB) Authoring & Updates The Investigator’s Brochure (IB) is a critical document within clinical trials, especially for therapeutic agents such as those involved in protac clinical trials….
Results Posting & Timelines Playbook for High-Profile and Late-Phase Trials The field of clinical research is governed by strict regulations and guidelines, especially when it comes to the transparency and disclosure of trial results. This article serves as a comprehensive playbook addressing the essential aspects of results posting and timelines specifically tailored for high-profile and…
Read More “Results Posting & Timelines Playbook for High-Profile and Late-Phase Trials” »
Digital Tools and Automation to Streamline Results Posting & Timelines Digital Tools and Automation to Streamline Results Posting & Timelines In the realm of clinical trials, the importance of transparency and timely results posting cannot be overstated. As regulatory bodies across the US, UK, and EU impose stringent guidelines for disclosing trial results, leveraging digital…
Read More “Digital Tools and Automation to Streamline Results Posting & Timelines” »
Vendor and Partner Oversight Considerations Related to Investigator’s Brochure (IB) Authoring & Updates In the realm of clinical research management, the role of the Investigator’s Brochure (IB) cannot be overstated. It serves as a crucial document that synthesizes key data about a clinical trial, including its objectives, design, methodologies, and safety information. Given its importance,…
Common Pitfalls in Results Posting & Timelines—and How to Avoid Costly Findings Common Pitfalls in Results Posting & Timelines—and How to Avoid Costly Findings In the field of clinical trials, the significance of transparent results posting and adherence to timelines cannot be overstated. The polarix clinical trial serves as an exemplary case, illustrating the need…
Read More “Common Pitfalls in Results Posting & Timelines—and How to Avoid Costly Findings” »
Aligning Results Posting & Timelines With ICH, GCP and Transparency Regulations Aligning Results Posting & Timelines With ICH, GCP and Transparency Regulations In the evolving landscape of clinical research, the necessity for transparent reporting of clinical trial results has gained paramount importance. Regulatory bodies across the globe emphasize a commitment to transparency, which fosters public…
Read More “Aligning Results Posting & Timelines With ICH, GCP and Transparency Regulations” »
Investigator’s Brochure (IB) Authoring & Updates for Oncology, Rare Disease and High-Risk Therapeutic Areas Investigator’s Brochure (IB) Authoring & Updates for Oncology, Rare Disease and High-Risk Therapeutic Areas The Investigator’s Brochure (IB) serves as a critical document in the context of clinical trials, especially for oncology, rare disease, and high-risk therapeutic areas. The IB not…
How to Design Results Posting & Timelines That Meets FDA, EMA and MHRA Expectations The design of results posting and timelines is a crucial aspect of clinical trials, particularly for ensuring compliance with regulatory agencies such as the FDA, EMA, and MHRA. As professionals in clinical operations, regulatory affairs, and medical affairs, it is essential…
Read More “How to Design Results Posting & Timelines That Meets FDA, EMA and MHRA Expectations” »
Results Posting & Timelines in Practice: Step-by-Step Guide for Sponsors and CROs In the increasingly regulated landscape of clinical research, the transparency of findings is more crucial than ever. With the focus on precision medicine and results dissemination, particularly within melanoma clinical trials, understanding the protocols for results posting and timelines is essential for sponsors…
Read More “Results Posting & Timelines in Practice: Step-by-Step Guide for Sponsors and CROs” »
Quality Control and Peer Review Processes for High-Stakes Investigator’s Brochure (IB) Authoring & Updates Quality Control and Peer Review Processes for High-Stakes Investigator’s Brochure (IB) Authoring & Updates The Investigator’s Brochure (IB) is an essential document in clinical trials, as it provides comprehensive information about a drug or device being tested. As a high-stakes document,…
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.